AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates

AngioDynamics (ANGO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 63.64%. A quarter ago, it was expected that this medical device maker would post a loss of $0.15 per share when it actually produced a loss of $0.11, delivering a surprise of 26.67%.Over the last four quarters, the company h ...